Implications of drug intoxication on donor utilization and outcomes in liver transplantation

被引:1
|
作者
Adjei, Michie [1 ]
Wisel, Steven A. [1 ,2 ]
Yang, Ju Dong [2 ,3 ]
Nissen, Nicholas N. [1 ,2 ]
Kim, Irene K. [1 ,2 ]
Steggerda, Justin A. [1 ,2 ,4 ]
机构
[1] Cedars Sinai Med Ctr, Dept Surg, Los Angeles, CA USA
[2] Cedars Sinai Med Ctr, Comprehens Transplant Ctr, Los Angeles, CA USA
[3] Cedars Sinai Med Ctr, Dept Med, Div Gastroenterol & Hepatol, Los Angeles, CA USA
[4] Cedars Sinai Comprehens Transplant Ctr, 8900 Beverly Blvd, Second Floor, Los Angeles, CA 90049 USA
关键词
donor utilization; drug intoxication; graft survival; opioids crisis; DECEASED ORGAN DONORS; DONATION; EPIDEMIC; RATES;
D O I
10.1111/ctr.15276
中图分类号
R61 [外科手术学];
学科分类号
摘要
Introduction: This study evaluates the implications of drug intoxication (DI) on donor utilization and outcomes in liver transplantation (LT). Methods: The UNOS STAR database was evaluated for all potential donors and adult, first-time, whole LT between 2005 and 2019. Logistic regression analyses evaluated liver utilization; proportional hazards modeling assessed risk of 1-year graft loss. Results: A total of 132 783 potential donors (10 205, 7.7% from DI), and 90 612 adult LT were identified (7490, 8.3% from DI). DI donors had median age 32 years (IQR 26-40 years, p < .001), were 42.6% female (n = 4346), and 15.5% were DCD donors (n = 1583). Utilization of DI donors changed over time, such that by 2015-2019 they were the most likely donor cause of death (COD) to be utilized. Among LT recipients, there were insignificant differences (<2% variance) in age, gender, ethnicity, and etiology of liver disease according to donor COD. Recipients with MELD scores >30 more frequently received grafts from donors with trauma (23.8%) and DI (21.8%) versus cardiovascular (20.0%) and CVA/stroke (19.9%, p < .001). Among DBD donors, DI-COD was associated with superior 1-year graft survival compared to donors from trauma (HR 1.172, 95% CI 1.057-1.300) and CVA/stroke (HR 1.404, 95% CI 1.264-1.561, p < .001). Donor COD was not significantly associated with 1-year graft loss among DCD donors. Conclusions: There is an increased likelihood of donor utilization when COD is drug overdose and an increased likelihood of 1-year graft survival compared to donors from trauma, CVA/stroke, and other COD.
引用
收藏
页数:13
相关论文
共 50 条
  • [41] TRENDS IN UTILIZATION AND POST-TRANSPLANT OUTCOMES IN COVID-19 POSITIVE DECEASED DONOR LIVER TRANSPLANTATION
    Wang, Roy X.
    Abu-Gazala, Samir
    Mahmud, Nadim
    HEPATOLOGY, 2023, 78 : S234 - S235
  • [42] Impact of Donor Age on Outcomes after Living Donor Liver Transplantation.
    Hayashi, K.
    Gotoh, K.
    Eguchi, H.
    Iwagami, Y.
    Yamada, D.
    Asaoka, T.
    Noda, T.
    Kawamoto, K.
    Kobayashi, S.
    Umeshita, K.
    Doki, Y.
    Mori, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 969 - 969
  • [43] Short Term Donor Outcomes After Hepatectomy in Living Donor Liver Transplantation
    Dar, Faisal Saud
    Zia, Haseeb
    Bhatti, Abu Bakar Hafeez
    Rana, Atif
    Nazer, Rashid
    Kazmi, Rubab
    Khan, Etizaz-ud-Din
    Khan, Nasir Ayub
    Salih, Muhammad
    Shah, Najmul Hassan
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2016, 26 (04): : 272 - 276
  • [44] Outcomes of donor evaluation in adult-to-adult living donor liver transplantation
    Trotter, James F.
    Wisniewski, Karen A.
    Terrault, Norah A.
    Everhart, James E.
    Kinkhabwala, Milan
    Weinrieb, Robert M.
    Fair, Jeffrey H.
    Fisher, Robert A.
    Koffron, Alan J.
    Saab, Sammy
    Merion, Robert M.
    HEPATOLOGY, 2007, 46 (05) : 1476 - 1484
  • [45] Donor and recipient outcomes in right lobe adult living donor liver transplantation
    Ghobrial, RM
    Saab, S
    Lassman, C
    Lu, DSK
    Raman, S
    Limanond, P
    Kunder, G
    Marks, K
    Amersi, T
    Anselmo, D
    Chen, P
    Farmer, D
    Han, S
    Durazo, F
    Goldstein, LI
    Busuttil, RW
    LIVER TRANSPLANTATION, 2002, 8 (10) : 901 - 909
  • [47] IMPLICATIONS OF DONOR SPECIFIC ANTIBODIES ON OUTCOMES AFTER PANCREAS TRANSPLANTATION
    Mittal, Shruti
    Page, Suzanne
    Gilbert, James
    Friend, Peter J.
    Sharples, Edward J.
    Fuggle, Susan
    TRANSPLANT INTERNATIONAL, 2013, 26 : 36 - 36
  • [48] National Landscape of the Utilization of Living Donor Liver Allografts in Redo Liver Transplantation.
    Lopez, J. I.
    Nijhar, K.
    Mitchell, J.
    Zeiser, L. Bowles
    Key, K.
    Asamoah-Mensah, A.
    Thomas, A.
    Haneda, R.
    Romano, S. K.
    Huang, J.
    Massie, A.
    Cameron, A. M.
    Segev, D. L.
    King, E. A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 717 - 717
  • [49] National Trends in Extended Criteria Donor Utilization and Outcomes for Lung Transplantation
    Christie, Ian G.
    Chan, Ernest G.
    Ryan, John P.
    Harano, Takashi
    Morrell, Matthew
    Luketich, James D.
    Sanchez, Pablo G.
    ANNALS OF THORACIC SURGERY, 2021, 111 (02): : 421 - 426
  • [50] Utilization of extended donor criteria in liver transplantation:: a comprehensive review of the literature
    Nickkholgh, Arash
    Weitz, Juergen
    Encke, Jens
    Sauer, Peter
    Mehrabi, Arianeb
    Buechler, Markus W.
    Schmidt, Jan
    Schemmer, Peter
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2007, 22 : 29 - 36